Lucia Coraggio | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
IFN-α neutralizing antibodies distinguish LADA from early-onset type 1 diabetes	THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM	2025
No differences in kidney function decline between people with type 2 diabetes starting a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist: a real-world retrospective comparative observational study	CLINICAL THERAPEUTICS	2024
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes	DIABETES/METABOLISM RESEARCH AND REVIEWS	2023
Analysis of prognostic factors in COVID-19 hospitalized patients. an italian single-center case-control study	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES	2023
Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow-up study	DIABETES, OBESITY AND METABOLISM	2023
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes	DIABETES/METABOLISM RESEARCH AND REVIEWS	2023
Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a six months follow-up study: The CoVaDiab study I	DIABETES/METABOLISM RESEARCH AND REVIEWS	2022
Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study	DIABETES, OBESITY AND METABOLISM	2021
Short-term safety profile of Sars-Cov2 vaccination on glucose control. Continuous glucose monitoring data in people with autoimmune diabetes	DIABETES RESEARCH AND CLINICAL PRACTICE	2021
Effects of covid-19 lockdown on glucose control: continuous glucose monitoring data from people with diabetes on intensive insulin therapy	DIABETES CARE	2020
Clinical features of patients with type 2 diabetes with and without Covid-19: a case control study (CoViDiab I)	DIABETES RESEARCH AND CLINICAL PRACTICE	2020
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II)	CARDIOVASCULAR DIABETOLOGY	2020
Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I)	DIABETES RESEARCH AND CLINICAL PRACTICE	2020